GB0119823D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0119823D0
GB0119823D0 GB0119823A GB0119823A GB0119823D0 GB 0119823 D0 GB0119823 D0 GB 0119823D0 GB 0119823 A GB0119823 A GB 0119823A GB 0119823 A GB0119823 A GB 0119823A GB 0119823 D0 GB0119823 D0 GB 0119823D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0119823A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB0119823A priority Critical patent/GB0119823D0/en
Publication of GB0119823D0 publication Critical patent/GB0119823D0/en
Priority to AU2002331231A priority patent/AU2002331231A1/en
Priority to PCT/EP2002/009006 priority patent/WO2003016344A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3023—Lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
GB0119823A 2001-08-14 2001-08-14 Novel compounds Ceased GB0119823D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0119823A GB0119823D0 (en) 2001-08-14 2001-08-14 Novel compounds
AU2002331231A AU2002331231A1 (en) 2001-08-14 2002-08-12 Use of lung carcinoma antigen
PCT/EP2002/009006 WO2003016344A2 (en) 2001-08-14 2002-08-12 Use of lung carcinoma antigen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0119823A GB0119823D0 (en) 2001-08-14 2001-08-14 Novel compounds

Publications (1)

Publication Number Publication Date
GB0119823D0 true GB0119823D0 (en) 2001-10-10

Family

ID=9920387

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0119823A Ceased GB0119823D0 (en) 2001-08-14 2001-08-14 Novel compounds

Country Status (3)

Country Link
AU (1) AU2002331231A1 (en)
GB (1) GB0119823D0 (en)
WO (1) WO2003016344A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789200A (en) * 1996-10-31 1998-08-04 Smithkline Beecham Corporation Human ETS family member, ELF3
US7125969B1 (en) * 1996-11-27 2006-10-24 The Regents Of The University Of California ETS-related gene overexpressed in human breast and epithelial cancers
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
WO2000070092A1 (en) * 1999-05-14 2000-11-23 Chiron Corporation Expression of ets-domain proteins in cancer

Also Published As

Publication number Publication date
AU2002331231A1 (en) 2003-03-03
WO2003016344A2 (en) 2003-02-27
WO2003016344A3 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
GB0108800D0 (en) Novel compounds
AU2002359165A8 (en) Novel compounds
GB0106586D0 (en) Novel compounds
HUP0105407D0 (en) Novel compounds
GB0104259D0 (en) Novel compounds
GB0102470D0 (en) Novel compounds
GB0103866D0 (en) Novel compounds
GB0102713D0 (en) Novel compounds
GB0102711D0 (en) Novel compounds
GB0104970D0 (en) Novel compounds
GB0100184D0 (en) Novel compounds
GB0100185D0 (en) Novel compounds
GB0100186D0 (en) Novel compounds
GB0100187D0 (en) Novel compounds
GB0101334D0 (en) Novel compounds
GB0101437D0 (en) Novel Compounds
GB0102469D0 (en) Novel compounds
GB0100181D0 (en) Novel compounds
GB0102570D0 (en) Novel Compounds
GB0102571D0 (en) Novel Compounds
GB0102575D0 (en) Novel Compounds
GB0102576D0 (en) Novel compounds
GB0102578D0 (en) Novel Compounds
GB0102577D0 (en) Novel Compounds
GB0100180D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)